601 related articles for article (PubMed ID: 24550101)
1. Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.
Babu A; Templeton AK; Munshi A; Ramesh R
AAPS PharmSciTech; 2014 Jun; 15(3):709-21. PubMed ID: 24550101
[TBL] [Abstract][Full Text] [Related]
2. Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy.
Ganta S; Talekar M; Singh A; Coleman TP; Amiji MM
AAPS PharmSciTech; 2014 Jun; 15(3):694-708. PubMed ID: 24510526
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery systems using polymer nanoassemblies for cancer treatment.
Bae Y
Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
[No Abstract] [Full Text] [Related]
5. Polymeric nano-micelles: versatile platform for targeted delivery in cancer.
Mohamed S; Parayath NN; Taurin S; Greish K
Ther Deliv; 2014 Oct; 5(10):1101-21. PubMed ID: 25418269
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
[TBL] [Abstract][Full Text] [Related]
7. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review.
Indoria S; Singh V; Hsieh MF
Int J Pharm; 2020 May; 582():119314. PubMed ID: 32283197
[TBL] [Abstract][Full Text] [Related]
9. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.
Heneweer C; Gendy SE; Peñate-Medina O
Ther Deliv; 2012 May; 3(5):645-56. PubMed ID: 22834408
[TBL] [Abstract][Full Text] [Related]
10. Targeting liposomes toward novel pediatric anticancer therapeutics.
Federman N; Denny CT
Pediatr Res; 2010 May; 67(5):514-9. PubMed ID: 20118828
[TBL] [Abstract][Full Text] [Related]
11. Size matters: gold nanoparticles in targeted cancer drug delivery.
Dreaden EC; Austin LA; Mackey MA; El-Sayed MA
Ther Deliv; 2012 Apr; 3(4):457-78. PubMed ID: 22834077
[TBL] [Abstract][Full Text] [Related]
12. EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors.
Stylianopoulos T
Ther Deliv; 2013 Apr; 4(4):421-3. PubMed ID: 23557281
[No Abstract] [Full Text] [Related]
13. Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects.
Wang Y; Wei X; Zhang C; Zhang F; Liang W
Ther Deliv; 2010 Aug; 1(2):273-87. PubMed ID: 22816133
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine: An effective tool in cancer therapy.
Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
[TBL] [Abstract][Full Text] [Related]
15. Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions.
Garg NK; Tandel N; Jadon RS; Tyagi RK; Katare OP
Drug Discov Today; 2018 Sep; 23(9):1610-1621. PubMed ID: 29857164
[TBL] [Abstract][Full Text] [Related]
16. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
[TBL] [Abstract][Full Text] [Related]
17. Nanoengineered drug delivery systems for enhancing antibiotic therapy.
Kalhapure RS; Suleman N; Mocktar C; Seedat N; Govender T
J Pharm Sci; 2015 Mar; 104(3):872-905. PubMed ID: 25546108
[TBL] [Abstract][Full Text] [Related]
18. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
19. Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers.
Caldorera-Moore ME; Liechty WB; Peppas NA
Acc Chem Res; 2011 Oct; 44(10):1061-70. PubMed ID: 21932809
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain.
Leyva-Gómez G; Cortés H; Magaña JJ; Leyva-García N; Quintanar-Guerrero D; Florán B
Drug Discov Today; 2015 Jul; 20(7):824-37. PubMed ID: 25701281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
